Importantly, TIMAP overexpression in BL, DLBCL, and FL tissues suggests a broader role in B-cell lymphomagenesis, which prompts the investigation of its clinical significance as a prognostic marker and therapeutic target across lymphoma subtypes. The gene discussed is PPP1R16B; the disease is Burkitt lymphoma.